BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 26109344)

  • 1. Race-associated biological differences among Luminal A breast tumors.
    D'Arcy M; Fleming J; Robinson WR; Kirk EL; Perou CM; Troester MA
    Breast Cancer Res Treat; 2015 Jul; 152(2):437-48. PubMed ID: 26109344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Race-associated biological differences among luminal A and basal-like breast cancers in the Carolina Breast Cancer Study.
    Parada H; Sun X; Fleming JM; Williams-DeVane CR; Kirk EL; Olsson LT; Perou CM; Olshan AF; Troester MA
    Breast Cancer Res; 2017 Dec; 19(1):131. PubMed ID: 29228969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence.
    Keenan T; Moy B; Mroz EA; Ross K; Niemierko A; Rocco JW; Isakoff S; Ellisen LW; Bardia A
    J Clin Oncol; 2015 Nov; 33(31):3621-7. PubMed ID: 26371147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas.
    Huo D; Hu H; Rhie SK; Gamazon ER; Cherniack AD; Liu J; Yoshimatsu TF; Pitt JJ; Hoadley KA; Troester M; Ru Y; Lichtenberg T; Sturtz LA; Shelley CS; Benz CC; Mills GB; Laird PW; Shriver CD; Perou CM; Olopade OI
    JAMA Oncol; 2017 Dec; 3(12):1654-1662. PubMed ID: 28472234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 21-Gene recurrence scores: racial differences in testing, scores, treatment, and outcome.
    Lund MJ; Mosunjac M; Davis KM; Gabram-Mendola S; Rizzo M; Bumpers HL; Hearn S; Zelnak A; Styblo T; O'Regan RM
    Cancer; 2012 Feb; 118(3):788-96. PubMed ID: 21720988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of differentially expressed genes in breast tumors from African American compared with Caucasian women.
    Field LA; Love B; Deyarmin B; Hooke JA; Shriver CD; Ellsworth RE
    Cancer; 2012 Mar; 118(5):1334-44. PubMed ID: 21800289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial disparities in survival outcomes by breast tumor subtype among African American women in Memphis, Tennessee.
    Vidal G; Bursac Z; Miranda-Carboni G; White-Means S; Starlard-Davenport A
    Cancer Med; 2017 Jul; 6(7):1776-1786. PubMed ID: 28612435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial variation in breast tumor promoter methylation in the Carolina Breast Cancer Study.
    Conway K; Edmiston SN; Tse CK; Bryant C; Kuan PF; Hair BY; Parrish EA; May R; Swift-Scanlan T
    Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):921-30. PubMed ID: 25809865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial Differences in the Association Between Luminal Master Regulator Gene Expression Levels and Breast Cancer Survival.
    Byun JS; Singhal SK; Park S; Yi DI; Yan T; Caban A; Jones A; Mukhopadhyay P; Gil SM; Hewitt SM; Newman L; Davis MB; Jenkins BD; Sepulveda JL; De Siervi A; Nápoles AM; Vohra NA; Gardner K
    Clin Cancer Res; 2020 Apr; 26(8):1905-1914. PubMed ID: 31911546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced immortalization, HUWE1 mutations and other biological drivers of breast invasive carcinoma in Black/African American patients.
    Andey T; Attah MM; Akwaaba-Reynolds NA; Cheema S; Parvin-Nejad S; Acquaah-Mensah GK
    Gene; 2020 Dec; 763S():100030. PubMed ID: 34493366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular breast cancer subtypes in premenopausal African-American women, tumor biologic factors and clinical outcome.
    Ihemelandu CU; Leffall LD; Dewitty RL; Naab TJ; Mezghebe HM; Makambi KH; Adams-Campbell L; Frederick WA
    Ann Surg Oncol; 2007 Oct; 14(10):2994-3003. PubMed ID: 17647064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in gene-expression profiles in breast cancer between African and European-ancestry women.
    Ping J; Guo X; Ye F; Long J; Lipworth L; Cai Q; Blot W; Shu XO; Zheng W
    Carcinogenesis; 2020 Jul; 41(7):887-893. PubMed ID: 32267939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of clinical, societal, and treatment variables on racial differences in ER-/PR- breast cancer survival.
    Roseland ME; Schwartz K; Ruterbusch JJ; Lamerato L; Krajenta R; Booza J; Simon MS
    Breast Cancer Res Treat; 2017 Aug; 165(1):163-168. PubMed ID: 28547656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factors I and II receptors in the breast cancer survival disparity among African-American women.
    Kalla Singh S; Tan QW; Brito C; De León M; De León D
    Growth Horm IGF Res; 2010 Jun; 20(3):245-54. PubMed ID: 20347606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of differentially methylated genes in normal prostate tissues from African American and Caucasian men.
    Kwabi-Addo B; Wang S; Chung W; Jelinek J; Patierno SR; Wang BD; Andrawis R; Lee NH; Apprey V; Issa JP; Ittmann M
    Clin Cancer Res; 2010 Jul; 16(14):3539-47. PubMed ID: 20606036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor/progesterone receptor-negative breast cancers of young African-American women have a higher frequency of methylation of multiple genes than those of Caucasian women.
    Mehrotra J; Ganpat MM; Kanaan Y; Fackler MJ; McVeigh M; Lahti-Domenici J; Polyak K; Argani P; Naab T; Garrett E; Parmigiani G; Broome C; Sukumar S
    Clin Cancer Res; 2004 Mar; 10(6):2052-7. PubMed ID: 15041725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between estrogen receptor-negative breast cancer and timing of reproductive events differ between African American and European American women.
    Ambrosone CB; Zirpoli GR; Bovbjerg DH; Shankar J; Hong CC; McCann SE; Ruszczyk M; Khoury T; Yao S; Ciupak GL; Jandorf L; Pawlish KS; Bandera EV
    Cancer Epidemiol Biomarkers Prev; 2014 Jun; 23(6):1115-20. PubMed ID: 24718280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine and cytokine receptor genes of the adaptive immune response are differentially associated with breast cancer risk in American women of African and European ancestry.
    Quan L; Gong Z; Yao S; Bandera EV; Zirpoli G; Hwang H; Roberts M; Ciupak G; Davis W; Sucheston L; Pawlish K; Bovbjerg DH; Jandorf L; Cabasag C; Coignet JG; Ambrosone CB; Hong CC
    Int J Cancer; 2014 Mar; 134(6):1408-21. PubMed ID: 23996684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated Resistin Gene Expression in African American Estrogen and Progesterone Receptor Negative Breast Cancer.
    Vallega KA; Liu N; Myers JS; Yu K; Sang QX
    PLoS One; 2016; 11(6):e0157741. PubMed ID: 27314854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentially expressed transcripts and dysregulated signaling pathways and networks in African American breast cancer.
    Stewart PA; Luks J; Roycik MD; Sang QX; Zhang J
    PLoS One; 2013; 8(12):e82460. PubMed ID: 24324792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.